Investing in China to support today's consumption and tomorrow's innovation
700 million mobile phone subscribers creating a vibrant social space and commercial market
Dramatic emergence of the Chinese middle class
300 million strong and growing with expanding consumption and inevitable march toward modernity
Investing in Healthcare
Improving medical services and developing new drugs
Peer-to-Peer lending and Microfinance
Providing alternative financial services to build small businesses throughout China
We invest in private and public equity funds in order to access great investors at each stage
of the capital and innovation cycle. We have made over 50 targeted investments in China-focused funds
with top-tier managers and key sector exposure. A select sample is presented below.
Seed and early stage managers have played an impactful role in fueling dramatic innovation in China.
Sagamore seeks direct investment opportunities in non-strategic, but essential sectors in China such as
agriculture, financial services and consumer products.
Sagamore's founders have worked together since 2002 and have invested in over 100 funds and companies in
Asia and the US. Sagamore's first investments focused on biotechnology and expanded to fund and direct
investments in China with Sagamore China Partners I (SCP I) in 2006. The team raised subsequent funds SCP
II (2010), SCP III (2013) and SCP IV (2016). In total, Sagamore has over $400m in assets under management for
investing in opportunities in China.
Sagamore China Partners I
Sagamore China Partners II
Sagamore China Partners III
Sagamore China Partners IV
Led by seasoned entrepreneurs, founders Peter Brooks and Rodrigo Yang, the firm's five professionals are
based in Beijing (sourcing and diligence) and Hong Kong (investment analytics).
Sagamore has offices in Beijing, Hong Kong and Shanghai. We are always looking for exciting business
opportunities and new talent to join our team. Please contact us for more